Global X MSCI Portugal ETF (PGAL) Chart & Stock Price History → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free PGAL Stock Alerts $10.32 0.00 (0.00%) (As of 02/16/2024) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Global X MSCI Portugal ETF Stock Price Performance5 Day Performance0.00%1 Month Performance0.00%3 Month Performance+0.49%6 Month Performance+10.97%Year-To-Date Performance-3.01%1 Year Performance-5.32% Receive PGAL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X MSCI Portugal ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here PGAL Stock Chart for Thursday, April, 25, 2024 PGAL Chart by TradingView Global X MSCI Portugal ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/23/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/22/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/19/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/18/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/17/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million Get the Latest News and Ratings for PGAL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X MSCI Portugal ETF and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/15/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/12/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/11/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/10/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/09/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/08/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/05/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/04/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/03/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/02/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million04/01/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/29/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/28/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/27/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/26/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/25/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/22/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/21/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/20/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/19/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/18/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/15/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/14/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/13/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/12/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/11/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/08/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/07/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/06/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/05/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/04/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million03/01/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million02/29/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 millionThe World's First "$20 Trillion Drug?" (Ad)One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>>02/28/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million02/27/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million02/26/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million02/23/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million02/22/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million02/21/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million02/20/2024$10.32$10.32$10.32$10.2615,500 shs$9.91 million02/19/2024$10.32$10.32+0.05%$10.32$10.2615,500 shs$9.91 million02/16/2024$10.32$10.31-0.10%$10.31$10.2615,549 shs$9.90 million02/15/2024$10.31$10.32+0.10%$10.32$10.183,267 shs$9.91 million02/14/2024$10.31$10.31+0.05%$10.31$10.3147 shs$9.90 million02/13/2024$10.30$10.31+0.05%$10.31$10.31295 shs$9.89 million02/12/2024$10.30$10.30$10.30$10.29665 shs$9.89 million02/09/2024$10.30$10.30$10.30$10.29364 shs$9.89 million02/08/2024$10.30$10.30$10.30$10.28966 shs$9.89 million02/07/2024$10.30$10.30$10.30$10.271,708 shs$9.89 million02/06/2024$10.30$10.30$10.31$10.301,029 shs$9.89 million02/05/2024$10.31$10.30-0.09%$10.30$10.281,956 shs$9.89 million02/02/2024$10.31$10.31$10.31$10.291,174 shs$9.90 million02/01/2024$10.30$10.31+0.10%$10.31$10.27266,496 shs$9.90 million01/31/2024$10.31$10.30-0.10%$10.30$10.3062 shs$9.89 million01/30/2024$10.30$10.31+0.10%$10.32$10.31160 shs$9.90 million01/29/2024$10.23$10.30+0.68%$10.31$10.2227,061 shs$9.89 million01/26/2024$10.27$10.23-0.39%$10.23$10.2357 shs$9.82 million01/25/2024$10.32$10.27-0.48%$10.27$10.27216 shs$9.86 million01/24/2024$10.25$10.32+0.68%$10.32$10.3246 shs$9.91 million Related Companies: Global X MSCI China Communication Services ETF Stock Price Chart Blackrock U.S. Industry Rotation ETF Stock Price Chart Defiance Nasdaq 100 Enhanced Options Income ETF Stock Price Chart Xtrackers USD High Yield BB-B ex Financials ETF Stock Price Chart Hartford Multifactor International Small Company ETF Stock Price Chart Hartford US Quality Growth ETF Stock Price Chart Invesco Bulletshares 2033 Municipal Bond ETF Stock Price Chart Blackrock Large Cap Core ETF Stock Price Chart Innovator Double Stacker 9 Buffer ETF - January Stock Price Chart Xtrackers MSCI All China Equity ETF Stock Price Chart Receive PGAL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Global X MSCI Portugal ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:PGAL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X MSCI Portugal ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.